{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:27:02Z","timestamp":1790170022649,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>E-cigarettes have emerged as an alternative to combustible cigarettes, yet their comparative impact on respiratory symptoms remains uncertain. We investigated cross-sectional differences in self-reported wheezing between current exclusive e-cigarette users, current exclusive cigarette smokers, and never-users of either product.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed data from 9000 adults aged\u2009\u2265\u200916 years in the 2017\u20132019 Scottish Health Survey. The exposure was current nicotine use status (exclusive cigarette smoking, exclusive e-cigarette use, or never-use), and the outcome was self-reported wheezing in the past 12 months. Binary multivariable logistic regression estimated adjusted odds ratios (ORs) with 95% confidence intervals (CIs), controlling for age, sex, area-level socioeconomic deprivation, longstanding illness, doctor-diagnosed asthma and COPD, self-rated general health, alcohol consumption, age of smoking initiation, and exposure to second-hand smoke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to exclusive e-cigarette users, exclusive cigarette smokers had significantly higher odds of wheezing (adjusted OR\u2009=\u20091.80, 95% CI: 1.33\u20132.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Never-users had lower odds of wheezing than exclusive e-cigarette users, though the difference was not significant (adjusted OR\u2009=\u20090.66, 95% CI: 0.31\u20131.40,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.275). Among exclusive cigarette smokers, the odds of wheezing increased with smoking intensity relative to exclusive e-cigarette users, indicating a dose-response relationship (\u03c7\u00b2 = 5.91,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018). Specifically, light smokers (&lt;\u200910 cigarettes\/day) had elevated but not significant odds (adjusted OR\u2009=\u20091.32, 95% CI: 0.92\u20131.89,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.133), while moderate smokers (10\u201319 cigarettes\/day) showed higher odds (adjusted OR\u2009=\u20091.85, 95% CI: 1.33\u20132.59,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and heavy smokers (\u2265\u200920 cigarettes\/day) had the greatest odds (adjusted OR\u2009=\u20092.27, 95% CI: 1.57\u20133.28,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Adjusted predicted probabilities of wheezing mirrored this pattern: compared with exclusive e-cigarette users, probabilities were significantly higher for moderate smokers (+\u20097.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and heavy smokers (+\u200910.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), but not for light smokers (+\u20093.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.152) or never-users (\u20133.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.306).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exclusive e-cigarette use was not associated with higher odds of wheezing compared with never-use, and it was linked to substantially lower odds than exclusive cigarette smoking. These findings suggest that, while complete abstinence remains the lowest-risk option, e-cigarette use may pose fewer respiratory symptoms than smoking, particularly for moderate-to-heavy smokers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01315-8","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:20:12Z","timestamp":1759490412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differences in respiratory wheezing between current exclusive e-cigarette users, current exclusive cigarette smokers, and never users of either product: findings from a population-based study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yusuff Adebayo","family":"Adebisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najim Z.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Spicuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Giacono","family":"Cantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venera","family":"Tomaselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Polosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1315_CR1","doi-asserted-by":"publisher","unstructured":"Chang JT, Anic GM, Rostron BL, Tanwar M, Chang CM. cigarette smoking reduction and health risks: a systematic review and meta-analysis. Nicotine Tob Res. 2021;23(4):635\u2013642. https:\/\/doi.org\/10.1093\/ntr\/ntaa156. PMID: 32803250.","DOI":"10.1093\/ntr\/ntaa156"},{"issue":"10","key":"1315_CR2","doi-asserted-by":"publisher","first-page":"e46532","DOI":"10.7759\/cureus.46532","volume":"15","author":"J Varghese","year":"2023","unstructured":"Varghese J, Muntode Gharde P. A comprehensive review on the impacts of smoking on the health of an individual. Cureus. 2023;15(10):e46532. https:\/\/doi.org\/10.7759\/cureus.46532. PMID: 37927763; PMCID: PMC10625450.","journal-title":"Cureus"},{"key":"1315_CR3","doi-asserted-by":"publisher","unstructured":"Jayes L, Haslam PL, Gratziou CG, Powell P, Britton J, Vardavas C, Jimenez-Ruiz C, Leonardi-Bee J, Tobacco control committee of the european respiratory society. SmokeHaz: systematic reviews and meta-analyses of the effects of smoking on respiratory health. Chest. 2016;150(1):164\u2009\u2013\u200979. https:\/\/doi.org\/10.1016\/j.chest.2016.03.060. Epub 2016 Apr 19. PMID: 27102185.","DOI":"10.1016\/j.chest.2016.03.060"},{"key":"1315_CR4","doi-asserted-by":"publisher","unstructured":"Adebisi YA, Alshahrani NZ, Ogunkola IO, Jimoh ND. Self-rated health by time since smoking cessation. Am J Prev Med. 2025 Aug 7:108040. https:\/\/doi.org\/10.1016\/j.amepre.2025.108040. Epub ahead of print. PMID: 40783088.","DOI":"10.1016\/j.amepre.2025.108040"},{"issue":"5","key":"1315_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/ijerph15051033","volume":"15","author":"A Strzelak","year":"2018","unstructured":"Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review. Int J Environ Res Public Health. 2018;15(5):1033. https:\/\/doi.org\/10.3390\/ijerph15051033. PMID: 29883409; PMCID: PMC5982072.","journal-title":"Int J Environ Res Public Health"},{"key":"1315_CR6","first-page":"12","volume":"528","author":"V Nguyen","year":"2023","unstructured":"Nguyen V, Jaqua EE, Tran MN, Simon LM. Respiratory symptom evaluation in adults: wheezing. FP Essent. 2023;528:12\u20138. PMID: 37220187.","journal-title":"FP Essent"},{"issue":"1","key":"1315_CR7","doi-asserted-by":"publisher","first-page":"e000981","DOI":"10.1136\/bmjresp-2021-000981","volume":"8","author":"N Berm\u00fadez Bar\u00f3n","year":"2021","unstructured":"Berm\u00fadez Bar\u00f3n N, Lindberg A, Stridsman C, Andersson M, Hedman L, Vikjord SA, Kankaanranta H, Lundb\u00e4ck B, R\u00f6nmark E, Backman H. Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma: a long-term prospective cohort study. BMJ Open Respir Res. 2021;8(1):e000981. https:\/\/doi.org\/10.1136\/bmjresp-2021-000981. PMID: 34281917; PMCID: PMC8291305.","journal-title":"BMJ Open Respir Res"},{"key":"1315_CR8","doi-asserted-by":"publisher","unstructured":"Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41(3):716\u2009\u2013\u200926. https:\/\/doi.org\/10.1183\/09031936.00073312. Epub 2012 Aug 16. PMID: 22903959.","DOI":"10.1183\/09031936.00073312"},{"issue":"11","key":"1315_CR9","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.jaip.2022.04.034","volume":"10","author":"NC Thomson","year":"2022","unstructured":"Thomson NC, Polosa R, Sin DD. Cigarette smoking and asthma. J Allergy Clin Immunol Pract. 2022;10(11):2783\u201397. https:\/\/doi.org\/10.1016\/j.jaip.2022.04.034. Epub 2022 May 6. PMID: 35533997.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1315_CR10","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.eclinm.2023.101936","volume":"59","author":"GBD 2019 Chronic Respiratory Diseases Collaborators","year":"2023","unstructured":"GBD 2019 Chronic respiratory diseases collaborators. Global burden of chronic respiratory diseases and risk factors, 1990\u20132019: an update from the global burden of disease study 2019. EClinicalMedicine. 2023;59:101936. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101936. PMID: 37229504; PMCID: PMC7614570.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1315_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12931-024-03051-2","volume":"26","author":"Z Wang","year":"2025","unstructured":"Wang Z, Lin J, Liang L, Huang F, Yao X, Peng K, Gao Y, Zheng J. Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the global burden of disease study 2021. Respir Res. 2025;26(1):2. https:\/\/doi.org\/10.1186\/s12931-024-03051-2. PMID: 39748260; PMCID: PMC11697803.","journal-title":"Respir Res"},{"issue":"2","key":"1315_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11739-024-03817-y","volume":"20","author":"YA Adebisi","year":"2025","unstructured":"Adebisi YA, Bafail DA. Comparing self-rated health among exclusive e-cigarette users and traditional cigarette smokers: an analysis of the health survey for England 2019. Intern Emerg Med. 2025;20(2):441\u201352. https:\/\/doi.org\/10.1007\/s11739-024-03817-y. Epub 2024 Nov 15. PMID: 39546077; PMCID: PMC11950125.","journal-title":"Intern Emerg Med"},{"issue":"8","key":"1315_CR13","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s11739-024-03716-2","volume":"19","author":"YA Adebisi","year":"2024","unstructured":"Adebisi YA, Bafail DA, Oni OE. Prevalence, demographic, socio-economic, and lifestyle factors associated with cigarette, e-cigarette, and dual use: evidence from the 2017\u20132021 Scottish health survey. Intern Emerg Med. 2024;19(8):2151\u201365. https:\/\/doi.org\/10.1007\/s11739-024-03716-2. Epub 2024 Jul 18. PMID: 39026065; PMCID: PMC11582201.","journal-title":"Intern Emerg Med"},{"key":"1315_CR14","doi-asserted-by":"publisher","unstructured":"Adebisi YA, Lucero-Prisno DE 3rd, Ogunkola IO. Self-rated health differences between exclusive e-cigarette users and exclusive cigarette smokers: evidence from the 2017\u20132019 Scottish Health Survey. Intern Emerg Med. 2025 Jan 31. https:\/\/doi.org\/10.1007\/s11739-025-03873-y. Epub ahead of print. PMID: 39888483.","DOI":"10.1007\/s11739-025-03873-y"},{"key":"1315_CR15","doi-asserted-by":"publisher","unstructured":"Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218\u2009\u2013\u200925. https:\/\/doi.org\/10.1159\/000360220. Epub 2014 Apr 3. PMID: 24714502.","DOI":"10.1159\/000360220"},{"key":"1315_CR16","doi-asserted-by":"publisher","first-page":"102951","DOI":"10.1016\/j.eclinm.2024.102951","volume":"79","author":"JD Sargent","year":"2024","unstructured":"Sargent JD, Lauten K, Edwards KC, Tanski SE, MacKenzie TA, Paulin LM, Brunette MF, Goniewicz ML, Malasky A, Stark D, de Moura FB, Griffin H, Nguyen KH, Backlund E, Kimmel HL, Kingsbury JH, Ozga JE, Cummings KM, Hyland A. Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2\u20136. EClinicalMedicine. 2024;79:102951. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102951. PMID: 39968205; PMCID: PMC11833018.","journal-title":"EClinicalMedicine"},{"key":"1315_CR17","doi-asserted-by":"publisher","first-page":"131828","DOI":"10.1016\/j.jhazmat.2023.131828","volume":"457","author":"N Ali","year":"2023","unstructured":"Ali N, Xavier J, Engur M, Pv M, Bernardino de la Serna J. The impact of e-cigarette exposure on different organ systems: a review of recent evidence and future perspectives. J Hazard Mater. 2023;457:131828. https:\/\/doi.org\/10.1016\/j.jhazmat.2023.131828. Epub 2023 Jun 12. PMID: 37320902.","journal-title":"J Hazard Mater"},{"key":"1315_CR18","doi-asserted-by":"publisher","unstructured":"Selya A, La Rosa GRM, Spicuzza L, Morjaria JB, Caci G, Polosa R. Association between electronic cigarette use and respiratory outcomes among people with no established smoking history: a comprehensive review and critical appraisal. Intern Emerg Med. 2025 Feb 24. https:\/\/doi.org\/10.1007\/s11739-025-03894-7. Epub ahead of print. PMID: 39992483.","DOI":"10.1007\/s11739-025-03894-7"},{"key":"1315_CR19","doi-asserted-by":"crossref","unstructured":"Morjaria JB, Campagna D, Caci G, O\u2019Leary R, Polosa R. Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence. Expert Rev Respir Med. 2022 Nov-Dec;16(11\u201312):1213\u201326. Epub 2023 Jan 22. PMID: 36638185.","DOI":"10.1080\/17476348.2023.2167716"},{"key":"1315_CR20","unstructured":"Scottish Government. Scottish Health Survey-Local area level data. Accessed via: https:\/\/statistics.gov.scot\/data\/scottish-health-survey-local-area-level-data Accessed: 20 March 2025."},{"key":"1315_CR21","unstructured":"Scottish Health Survey. interviewee information and privacy notice. Accessed via: https:\/\/www.gov.scot\/publications\/scottish-health-survey-interviewee-faqs\/ Accessed: 20 March 2025."},{"issue":"11","key":"1315_CR22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1164\/rccm.202107-1718OC","volume":"205","author":"W Xie","year":"2022","unstructured":"Xie W, Tackett AP, Berlowitz JB, Harlow AF, Kathuria H, Galiatsatos P, Fetterman JL, Cho J, Blaha MJ, Hamburg NM, Robertson RM, DeFilippis AP, Hall ME, Bhatnagar A, Benjamin EJ, Stokes AC. Association of electronic cigarette use with respiratory symptom development among U.S. young adults. Am J Respir Crit Care Med. 2022;205(11):1320\u20139. https:\/\/doi.org\/10.1164\/rccm.202107-1718OC. PMID: 35089853; PMCID: PMC9873120.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1315_CR23","doi-asserted-by":"publisher","first-page":"e0299834","DOI":"10.1371\/journal.pone.0299834","volume":"19","author":"E Karey","year":"2024","unstructured":"Karey E, Xu S, He P, Niaura RS, Cleland CM, Stevens ER, Sherman SE, El-Shahawy O, Cantrell J, Jiang N. Longitudinal association between e-cigarette use and respiratory symptoms among US adults: findings from the population assessment of tobacco and health study waves 4\u20135. PLoS ONE. 2024;19(2):e0299834. https:\/\/doi.org\/10.1371\/journal.pone.0299834. PMID: 38421978; PMCID: PMC10903800.","journal-title":"PLoS ONE"},{"issue":"4","key":"1315_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.amepre.2022.10.006","volume":"64","author":"JB Berlowitz","year":"2023","unstructured":"Berlowitz JB, Xie W, Harlow AF, Blaha MJ, Bhatnagar A, Benjamin EJ, Stokes AC. Cigarette\u2013e-cigarette transitions and respiratory symptom development. Am J Prev Med. 2023;64(4):556\u201360. https:\/\/doi.org\/10.1016\/j.amepre.2022.10.006. Epub 2022 Dec 5. PMID: 36470837; PMCID: PMC10033326.","journal-title":"Am J Prev Med"},{"issue":"2","key":"1315_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/tobaccocontrol-2018-054694","volume":"29","author":"D Li","year":"2020","unstructured":"Li D, Sundar IK, McIntosh S, Ossip DJ, Goniewicz ML, O\u2019Connor RJ, Rahman I. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the population assessment of tobacco and health (PATH) study, wave 2. Tob Control. 2020;29(2):140\u20137. https:\/\/doi.org\/10.1136\/tobaccocontrol-2018-054694. Epub 2019 Feb 13. PMID: 30760629; PMCID: PMC6692241.","journal-title":"Tob Control"},{"issue":"4","key":"1315_CR26","doi-asserted-by":"publisher","first-page":"e236247","DOI":"10.1001\/jamanetworkopen.2023.6247","volume":"6","author":"LM S\u00e1nchez-Romero","year":"2023","unstructured":"S\u00e1nchez-Romero LM, Bondarenko I, Knoll M, Hirschtick JL, Cook S, Fleischer NL, Levy DT. Assessment of electronic nicotine delivery systems with cigarette use and self-reported wheezing in the US adult population. JAMA Netw Open. 2023;6(4):e236247. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.6247. PMID: 37010872; PMCID: PMC10071334.","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"1315_CR27","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1093\/ntr\/ntaa199","volume":"22","author":"LM Schneller","year":"2020","unstructured":"Schneller LM, Qui\u00f1ones Tav\u00e1rez Z, Goniewicz ML, Xie Z, McIntosh S, Rahman I, O\u2019Connor RJ, Ossip DJ, Li D. Cross-sectional association between exclusive and concurrent use of cigarettes, ENDS, and cigars, the three most popular tobacco products, and wheezing symptoms among U.S. adults. Nicotine Tob Res. 2020;22(Suppl 1):S76\u201384. https:\/\/doi.org\/10.1093\/ntr\/ntaa199. PMID: 33320256; PMCID: PMC8224835.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"1315_CR28","doi-asserted-by":"publisher","first-page":"28549","DOI":"10.1038\/s41598-024-80221-8","volume":"14","author":"JZ Goicoechea","year":"2024","unstructured":"Goicoechea JZ, Boughner A, Lee JJC, Mahajan A, Yeo K, Sproga M, Russell C, Coughlan M, Selya A, Caci G, Caponnetto P, Tomaselli V, Polosa R. Respiratory symptoms among e-cigarette users without an established smoking history in the VERITAS cohort. Sci Rep. 2024;14(1):28549. https:\/\/doi.org\/10.1038\/s41598-024-80221-8. PMID: 39558006; PMCID: PMC11574031.","journal-title":"Sci Rep"},{"issue":"2","key":"1315_CR29","doi-asserted-by":"publisher","first-page":"100295","DOI":"10.1016\/j.clinme.2025.100295","volume":"25","author":"G Caci","year":"2025","unstructured":"Caci G, Selya A, La Rosa GRM, Spicuzza L, Morjaria JB, Geraci G, Polosa R. Respiratory effects of electronic cigarette use in individuals who never smoked: a systematic review. Clin Med (Lond). 2025;25(2):100295. https:\/\/doi.org\/10.1016\/j.clinme.2025.100295. Epub ahead of print. PMID: 39993529; PMCID: PMC11930579.","journal-title":"Clin Med (Lond)"},{"key":"1315_CR30","doi-asserted-by":"publisher","unstructured":"Qureshi MA, Vernooij RWM, La Rosa GRM, Polosa R, O\u2019Leary R. Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review. Harm Reduct J. 2023;20(1):143. https:\/\/doi.org\/10.1186\/s12954-023-00877-9. Erratum in: Harm Reduct J. 2024;21(1):60. doi: 10.1186\/s12954-024-00968-1. PMID: 37794458; PMCID: PMC10552385.","DOI":"10.1186\/s12954-023-00877-9"},{"issue":"1","key":"1315_CR31","doi-asserted-by":"publisher","first-page":"e3955","DOI":"10.7759\/cureus.3955","volume":"11","author":"A Hussain","year":"2019","unstructured":"Hussain A, Dulay P, Rivera MN, Aramouni C, Saxena V. Neoplastic pathogenesis associated with cigarette carcinogens. Cureus. 2019;11(1):e3955. https:\/\/doi.org\/10.7759\/cureus.3955. PMID: 30956908; PMCID: PMC6436676.","journal-title":"Cureus"},{"issue":"9","key":"1315_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/17476348.2019.1649146","volume":"13","author":"R Polosa","year":"2019","unstructured":"Polosa R, O\u2019Leary R, Tashkin D, Emma R, Caruso M. The effect of e-cigarette aerosol emissions on respiratory health: a narrative review. Expert Rev Respir Med. 2019;13(9):899\u2013915. Epub 2019 Aug 2. PMID: 31375047.","journal-title":"Expert Rev Respir Med"},{"key":"1315_CR33","doi-asserted-by":"publisher","unstructured":"Vojjala M, Stevens ER, Nicholson A, Morgan T, Kaneria A, Xiang G, Wilker O, Wisniewski R, Melnic I, El Shahawy O, Berger KI, Sherman SE. Switching to e-cigarettes as harm reduction among individuals with chronic disease who currently smoke: results of a pilot randomized controlled trial. Nicotine Tob Res. 2024;27(1):36\u201345. https:\/\/doi.org\/10.1093\/ntr\/ntae158. PMID: 38995184.","DOI":"10.1093\/ntr\/ntae158"},{"issue":"6","key":"1315_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.6061\/clinics\/2016(06)10","volume":"71","author":"DM Utiyama","year":"2016","unstructured":"Utiyama DM, Yoshida CT, Goto DM, de Santana Carvalho T, de Paula Santos U, Koczulla AR, Saldiva PH, Nakagawa NK. The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clin (Sao Paulo). 2016;71(6):344\u201350. https:\/\/doi.org\/10.6061\/clinics\/2016(06)10. PMID: 27438569; PMCID: PMC4930664.","journal-title":"Clin (Sao Paulo)"},{"issue":"1","key":"1315_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-2600(19)30276-0","volume":"8","author":"EC Oelsner","year":"2020","unstructured":"Oelsner EC, Balte PP, Bhatt SP, Cassano PA, Couper D, Folsom AR, Freedman ND, Jacobs DR Jr, Kalhan R, Mathew AR, Kronmal RA, Loehr LR, London SJ, Newman AB, O\u2019Connor GT, Schwartz JE, Smith LJ, White WB, Yende S. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI pooled cohorts study. Lancet Respir Med. 2020;8(1):34\u201344. https:\/\/doi.org\/10.1016\/S2213-2600(19)30276-0. Epub 2019 Oct 9. PMID: 31606435; PMCID: PMC7261004.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"1315_CR36","doi-asserted-by":"publisher","first-page":"18667","DOI":"10.1038\/s41598-021-98156-9","volume":"11","author":"YJ Yoon","year":"2021","unstructured":"Yoon YJ, Lee MS, Jang KW, Ahn JB, Hurh K, Park EC. Association between smoking cessation and obstructive spirometry pattern among Korean adults aged 40\u201379 years. Sci Rep. 2021;11(1):18667. https:\/\/doi.org\/10.1038\/s41598-021-98156-9. PMID: 34548552; PMCID: PMC8455662.","journal-title":"Sci Rep"},{"key":"1315_CR37","doi-asserted-by":"publisher","unstructured":"Freund KM, Belanger AJ, D\u2019Agostino RB, Kannel WB. The health risks of smoking. The framingham study: 34 years of follow-up. Ann Epidemiol. 1993;3(4):417\u2009\u2013\u200924. https:\/\/doi.org\/10.1016\/1047-2797(93)90070-k. PMID: 8275219.","DOI":"10.1016\/1047-2797(93)90070-k"},{"issue":"Suppl 1","key":"1315_CR38","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1093\/ntr\/ntaa150","volume":"22","author":"RN Cassidy","year":"2020","unstructured":"Cassidy RN, Tidey JW, Colby SM, Exclusive E-C. Users report lower levels of respiratory symptoms relative to dual e-cigarette and cigarette users. Nicotine Tob Res. 2020;22(Suppl 1):S54\u201360. https:\/\/doi.org\/10.1093\/ntr\/ntaa150. PMID: 32808033; PMCID: PMC7737479.","journal-title":"Nicotine Tob Res"},{"key":"1315_CR39","doi-asserted-by":"publisher","first-page":"1179173X2513254","DOI":"10.1177\/1179173X251325421","volume":"18","author":"GRM La Rosa","year":"2025","unstructured":"La Rosa GRM, Polosa R, O\u2019Leary R. Patterns of use of e-cigarettes and their respiratory effects: A critical umbrella review. Tob Use Insights. 2025;18:1179173X251325421. https:\/\/doi.org\/10.1177\/1179173X251325421. PMID: 40078697; PMCID: PMC11898095.","journal-title":"Tob Use Insights"},{"issue":"7","key":"1315_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/17476348.2018.1483724","volume":"12","author":"A Ratajczak","year":"2018","unstructured":"Ratajczak A, Feleszko W, Smith DM, Goniewicz M. How close are we to definitively identifying the respiratory health effects of e-cigarettes?. Expert Rev Respir Med. 2018;12(7):549\u201356. https:\/\/doi.org\/10.1080\/17476348.2018.1483724. Epub 2018 Jun 8. PMID: 29856662; PMCID: PMC6310477.","journal-title":"Expert Rev Respir Med"},{"key":"1315_CR41","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.jemep.2025.101117","volume":"33","author":"YA Adebisi","year":"2025","unstructured":"Adebisi YA, Lungu S, Curado A, Oke G, Yach D. Understanding research gaps and priorities for tobacco harm reduction in low-income and middle-income countries. Ethics Med Public Health. 2025;33:101117.","journal-title":"Ethics Med Public Health"},{"key":"1315_CR42","unstructured":"Adebisi YA, Alshahrani NZ. Predictors of e-cigarette use among individuals with asthma: findings from a cross-sectional population-based study. Intern Emerg Med. 2025 Jul;12:1\u20139."},{"issue":"25","key":"1315_CR43","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1016\/j.jacc.2019.09.067","volume":"74","author":"J George","year":"2019","unstructured":"George J, Hussain M, Vadiveloo T, Ireland S, Hopkinson P, Struthers AD, Donnan PT, Khan F, Lang CC. Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes. J Am Coll Cardiol. 2019;74(25):3112\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.067. Epub 2019 Nov 15. PMID: 31740017; PMCID: PMC6928567.","journal-title":"J Am Coll Cardiol"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01315-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:20:16Z","timestamp":1759490416000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01315-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01315-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a secondary analysis of publicly available, anonymised data. No ethical approval was sought.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As this study involved secondary data analysis, no ethical approval or informed consent was required by the authors for this research, as it qualifies for exemption from human subjects research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Najim Z. Alshahrani, Lucia Spicuzza, Venera Tomaselli, Giulio Giacono Cantone, Giulio Geraci, and Francesco Pennisi declare no conflict of interest. Yusuff Adebayo Adebisi received funding in the past through the Tobacco Harm Reduction Scholarship and the Kevin Molloy Fellowship, both awarded by Knowledge-Action-Change (KAC) UK, an independent public health organisation. KAC receives funding from Global Action to End Smoking (GA), an independent U.S. nonprofit 501(c)(3) grantmaking organisation that supports health and science research, cessation education, and agricultural transformation initiatives. Riccardo Polosa is a full tenured professor of Internal Medicine at the University of Catania (Italy) and Medical Director of the Institute for Internal Medicine at the same university. He has received the following EU and governmental competitive grants: U-BIOPRED, AIR-PROM, Integral Rheumatology & Immunology Specialists Network (IRIS), and several PNRR grants (PNRR 3277\/2021, PNRR 341\/2022, PNRR 411\/2021) funded by NextGenerationEU of the European Commission. He has also received investigator-initiated grants from GA, Pfizer, GlaxoSmithKline, CV Therapeutics, NeuroSearch A\/S, Sandoz, Merk Sharp & Dohme, Boehringer Ingelheim, Novartis, Arbi Group Srl., Duska Therapeutics, and Forest Laboratories. He is the founder of the Center for Tobacco Prevention and Treatment (CPCT) and the Center of Excellence for the Acceleration of Harm Reduction at Catania University. He has received consultancy fees from Pfizer, Boehringer Ingelheim, Duska Therapeutics, Forest Laboratories, CV Therapeutics, Sermo Inc., GRG Health, Clarivate Analytics, Guidepoint Expert Network, and GLG Group. He receives textbook royalties from Elsevier and EDRA. He is also Chair of the European Technical Committee for Standardisation on \u201cRequirements and test methods for emissions of electronic cigarettes\u201d (CEN\/TC 437; WG4) and scientific advisor of the non-profit Foundation RIDE2Med. This research was conducted independently and is not linked to any prior funding sources.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}